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Ending HIV/AIDS: Not as close as 
many would have us believe
To the Editor: Declarations regarding the global elimination of HIV 
(the end of AIDS) would suggest that current efforts at prevention 
and treatment are close to being 100% effective.[1] The widespread 
roll-out and success of antiretroviral therapy (ART) for treating HIV, 
the promise of pre-exposure prophylaxis (PrEP) and the universal 
test-and-treat approach support such claims. In South Africa (SA), 
the success of programmes regarding prevention of mother-to-
child-transmission (PMTCT) and a plethora of community-wide 
combination prevention programmes, suggest a slowing of HIV 
acquisition, also pointing to the end of HIV/AIDS. However, the 
recent publication of the failed PopART (effect of universal testing 
and treatment on HIV incidence) study[2] and continuing new 
infections within our longitudinal work in SA, suggest little slowing, 
let alone elimination, as we indicate below. 
From May 2009 to January 2010, 98% (N=1 238) of pregnant 
women in 24 matched, Cape Town township neighbourhoods were 
recruited. Mothers and children were assessed at 2 weeks after birth, 
and 0.5, 1.5, 3, 5 and 8 years after birth, with a high retention rate 
(83 - 96%).[3] Approximately 10% (n=127) of mothers and children 
died over 8 years. Mothers’ HIV status was self-reported at each 
assessment and validated with their children’s government-issued 
Road-to-Health card. Rapid HIV tests were also conducted at the 
8-year assessment. At the baseline assessment, 99% of women had 
been tested for HIV at their antenatal visit and 26% (n=324/1 238) were 
HIV-positive. At the 8-year assessment, HIV status was determined 
in two ways: 
• Mothers (n=601) were tested with HIV rapid diagnostic tests (HIV 
RDTs); 45% of mothers were HIV-positive (n=269/601).
• The remaining 303 mothers in the study had been tested antenatally 
or during the 8 years, and their status was reported on their child’s 
Road-to-Health card; 47% were HIV-positive (n=141/303). 
Among the mothers completing the HIV RDTs, 36 reported that they 
were HIV-seronegative, but tested seropositive for HIV, reflecting a 
6% discrepancy between self-reports and HIV test results. 
Despite broad implementation of HIV prevention and treatment, 
HIV continues to spread among SA women. During the period 
of the broadest expansion of HIV services, an additional 17% of 
mothers became infected with HIV. Monitoring new infections 
among township mothers indicates that the broad expansion of HIV 
services in SA has not resulted in fewer HIV infections. 
Estimates from the Global Burden of Diseases, Injuries, and Risk 
Factors (GBD) study are that, in sub-Saharan Africa, HIV/AIDS will 
remain one of the leading causes of years of life lost in 2040, and that 
there is a real risk of HIV mortality rebounding, thus jeopardising 
the massive progress achieved to date.[4] The recent failure of large 
community-based trials in the same area,[2] coupled with our findings 
from SA, reflect the ongoing urgency of maintaining a focus on HIV 
and expanding services beyond the medical delivery of HIV testing 
and treatment to prevent a rebound in HIV mortality.[4] 
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